Poor Outcomes of Girdlestone Resection Arthroplasty in Injection Drug Users: A Retrospective Study
Henry T. Shu(Johns Hopkins University), Babar Shafiq(Johns Hopkins University), Greg Osgood(Johns Hopkins Hospital), Diane Ghanem(Johns Hopkins University), Jamie Ferguson(Nuffield Orthopaedic Centre), Alice J. Hughes(Johns Hopkins University), Janet D. Conway(Sinai Hospital), Zaid Elsabbagh(Apple (Israel)), Rachel B. Sotsky(Johns Hopkins University), Oscar Covarrubias(Johns Hopkins Hospital)
Cited by 1
Related Papers
Racial Disparity in Time to Surgery and Complications for Hip Fracture Patients
|Clinics in Orthopedic Surgery|2020|65
Does use of glucagon-like peptide-1 agonists increase perioperative complications in patients undergoing shoulder arthroplasty?
|Journal of Shoulder and Elbow Surgery|2024|24
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study
|JCO Precision Oncology|2024|5
Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective Study
|JCO Precision Oncology|2025|5
The associations of comorbidities with healthcare utilization among patients undergoing total shoulder arthroplasty
|Seminars in Arthroplasty JSES|2025|2